Lloyds non-exec buys ahead of IMS

20th Apr 2010 16:31

Lloyds Banking Group non-executive director Dr Wolfgang Berndt has added to his shareholding. Dr Berndt paid 65.98p a share for 51,571 shares for a total investment of £34,027. Dr Berndt invested £201,000 in shares from the rights issue at the end of 2009. the rights issue price was 37p a share. He also invested nearly £60,000 in the June open offer at 38.43p a share. He owns exactly 1m shares, which is four times the number he owned one year ago. Dr Berndt spent more than three decades with Procter & Gamble before retiring in 2001. He joined the Lloyds board in 2003. In the first 10 weeks of 2010, Lloyds trading has been strong and costs have been reduced. Impairment provisions are also expected to reduce. The company expects to be profitable this year. Lloyds will publish its Interim Management Statement on 27 April. Top Director BuysDaisy Group (DAY) Director name: Mr Matthew RileyAmount purchased: 100,000 @ 92.00p Value: £92,000Lloyds Banking Group (LLOY) Director name: Dr Wolfgang C G BerndtAmount purchased: 51,571 @ 65.98p Value: £34,027Top Director SellsBankers Petroleum Ltd (BNK) Director name: Mr Robert M D CrossAmount sold: 1,000,000 @ 573.80p Value: £5,738,000